A convertible note matured 7/15 but will be done by then.
Thereafter, the CEO said next convertible is end of July, then Sept.
So there's a 4 -7 day window coming up to buy DRU*S and everyone on the board is expecting a HUGE RALLY--- possibly 10+ cents
DRU*S has $25M in revenues (which was audited). Mkt cap is only 2.2M, and OS is ~275M with recent conversions
FOLLOW ME ON TWITTER => https://twitter.com/CountryRocks561
Recent DXR News
- New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™) • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 • GlobeNewswire Inc. • 03/22/2024 12:00:00 PM
- Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 • GlobeNewswire Inc. • 03/18/2024 06:18:00 PM
- Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders • GlobeNewswire Inc. • 03/18/2024 06:18:00 PM
- Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend] • Edgar (US Regulatory) • 03/08/2024 06:49:31 PM
- Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients • GlobeNewswire Inc. • 03/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:18:32 PM
- Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend] • Edgar (US Regulatory) • 02/29/2024 10:28:32 PM
- Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report) • Edgar (US Regulatory) • 02/29/2024 09:15:19 PM
- Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions • GlobeNewswire Inc. • 02/12/2024 01:00:00 PM
- Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:52:42 PM
- Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer • GlobeNewswire Inc. • 01/02/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 08:48:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 02:00:56 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM